NCT00878202

Brief Summary

The purpose of the SEDIC study is to test a home based heart failure patient clinical follow-up and therapeutic education using telemedicine. This educational follow-up is based on an interactive information system (SCAD) including a touch screen personal computer for heart failure patient at home. An interactive algorithm has been developed to allow a self management teaching to the patient.Furthermore, a specialized nurse provide a clinical data follow-up.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for phase_4 heart-failure

Timeline
Completed

Started Mar 2009

Typical duration for phase_4 heart-failure

Geographic Reach
1 country

6 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2009

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 6, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 8, 2009

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
Last Updated

February 20, 2013

Status Verified

February 1, 2013

Enrollment Period

3.3 years

First QC Date

April 6, 2009

Last Update Submit

February 19, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of hospitalization days for heart failure

    12 months

Secondary Outcomes (10)

  • Cardiovascular mortality

    12 months

  • Total mortality

    12 months

  • Rate of hospitalization for heart failure

    12 months

  • Median of time up to mortality or hospitalization for heart failure

    12 months

  • Number of medical consultation

    12 months

  • +5 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

Optimal medical treatment of Heart failure and therapeutic education

Telemedicine

EXPERIMENTAL

Optimal medical treatment of heart failure disease and therapeutic education

Device: SCAD information system

Interventions

Clinical follow-up and continuation of therapeutic education by telemedicine during 3 months

Telemedicine

Eligibility Criteria

Age65 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients \> 65 years old hospitalized for acute heart failure
  • Left ventricle systolic Dysfunction with ejection fraction \< 45 %, documented in the previous 6 months
  • And at least one of the following criteria:
  • BNP before discharge from hospital \> 350 pg/ml / EF \< 35 % / Hospitalization for acute heart failure informed in the previous 6 months

You may not qualify if:

  • NYHA 4 at hospital discharge
  • Planned cardiac surgery or coronary revascularization
  • Hospitalization for ST-elevation acute coronary syndrome
  • Depressive syndrome with score \> 20 at geriatric depression scale
  • Therapeutic education impossible
  • Technical problems with the device
  • Limited autonomy for device use
  • Patient not living in Basse-Normandie
  • Ongoing participation in another clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Alençon-Mamers Hospital

Alençon, 61000, France

Location

Caen University Hospital

Caen, France

Location

Cherbourg Hospital

Cherbourg, France

Location

Flers Hospital

Flers, France

Location

Lisieux Hospital

Lisieux, 14100, France

Location

Saint-Lo Hospital

Saint-Lô, 50009, France

Location

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Rémi Sabatier, MD

    University Hospital, Caen

    PRINCIPAL INVESTIGATOR
  • Annette Belin, MD

    University Hospital, Caen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 6, 2009

First Posted

April 8, 2009

Study Start

March 1, 2009

Primary Completion

June 1, 2012

Study Completion

June 1, 2012

Last Updated

February 20, 2013

Record last verified: 2013-02

Locations